REQUESTING THE DEPARTMENT OF HEALTH TO CONVENE A MEDICINAL PSILOCYBIN AND PSILOCIN WORKING GROUP TO EXAMINE THE MEDICINAL AND THERAPEUTIC EFFECTS OF PSILOCYBIN AND PSILOCIN AND DEVELOP A LONG-TERM STRATEGIC PLAN TO ENSURE THE AVAILABILITY OF MEDICINAL PSILOCYBIN AND PSILOCIN OR PSILOCYBIN-BASED AND PSILOCIN-BASED PRODUCTS THAT ARE SAFE, ACCESSIBLE, AND AFFORDABLE FOR ELIGIBLE ADULT PATIENTS.
Bill status
in committee
1 of 4 stages cleared
Introduction
Mar 2022
Committee Review
Floor Vote
Governor
Introduced Mar 11, 2022
Last action Mar 16, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Mar 16, 2022
Committee
Referred to HTH.
upper
Mar 11, 2022
Introduced
Offered.
upper
2 primary · 1 co-sponsor
Sponsors
Role
Legislator
Party
State
District
P
Joy San Buenaventura
DDemocratic
P
Stanley Chang
DDemocratic
Co
BE
Bennette E. Misalucha
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about SCR 227
Scope: HI
Hi! I can help you understand SCR 227. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline